BREAKTHROUGH could aid Lung Cancer patients
(01-26) 15:30 PST SAN FRANCISCO — In a finding that could improve the survival odds for early-stage lung cancer patients, UCSF researchers determined a new molecular test can predict more accurately than current diagnostic methods which tumors are more likely to be aggressive and turn deadly.
(Pictured on left) Lung cancer survivor, Bonnie Addario at her San Carlos, Ca. home on Thursday January 26, 2012. A new lung cancer study demonstrates the importance of genetic testing of early stage lung cancer tumors.
The study results, published today in the medical journal The Lancet, come from the two largest clinical trials ever conducted on the molecular genetics of lung cancer and included early-stage patients from Northern California Kaiser hospitals as well as from Read More













